Evidence map›Paper›PMID 35529436›Full record

ArticleFrontiers in pharmacology2022

Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands.

Chiara Sturaro, Davide Malfacini, Michela Argentieri, Francine M Djeujo, Erika Marzola, Valentina Albanese, Chiara Ruzza, Remo Guerrini, Girolamo Calo', Paola Molinari

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Frontiers in pharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Chiara SturaroDepartment of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Ferrara, Italy.
Davide MalfaciniDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Michela ArgentieriDepartment of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Ferrara, Italy.
Francine M DjeujoDepartment of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Erika MarzolaDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
Valentina AlbaneseDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
Chiara RuzzaDepartment of Neuroscience and Rehabilitation, Section of Pharmacology, University of Ferrara, Ferrara, Italy.
Remo GuerriniDepartment of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy.
Girolamo Calo'Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
Paola MolinariNational Center for Drug Research and Evaluation, National Institute of Health, Rome, Italy.
University of Ferrara · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study investigated the

Indexed as

biased agonismBRETcalcium mobilizationdyn A-palmiticG protein-coupled receptorkappa opioid receptorlabel-freePWT2-dyn A

Identifiers

PMID35529436
PMCPMC9068900
OpenAlexW4224293479

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.